Prospective longitudinal sequencing of tumor and circulating DNA to assess response to radiation and other therapies in patients with glioblastoma
Research Grant
Administered By
Duke Cancer Institute
Awarded By
Personalis, Inc.
Start Date
October 1, 2022
End Date
November 30, 2024
Administered By
Duke Cancer Institute
Awarded By
Personalis, Inc.
Start Date
October 1, 2022
End Date
November 30, 2024